J Med Microbiol 53 (2004), 451-453; DOI: 10.1099/jmm.0.05328-0
© 2004 Society for General Microbiology
ISSN 0022-2615
Case of aortic endocarditis caused by Lactobacillus casei
L. Zé-Zé1,
R. Tenreiro1,
A. Duarte2,
M. J. Salgado3,
J. Melo-Cristino3,4,
L. Lito3,
M. M. Carmo3,
S. Felisberto5 and
G. Carmo5
1Departamento de Biologia Vegetal e Centro de Genética e Biologia Molecular, Faculdade de Ciências, Universidade de Lisboa, Campo Grande, 1749-016 Lisboa, Portugal 2Departamento de Microbiologia, Faculdade de Farmácia, Universidade de Lisboa, 1649-019 Lisboa, Portugal 3,5Laboratório de Bacteriologia3 and Departamento de Doenças Infecto-Contagiosas5, Hospital de Santa Maria, 1649-035 Lisboa, Portugal 4Laboratório de Microbiologia, Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisboa, Portugal
Correspondence L. Zé-Zé lmze-ze{at}fc.ul.pt
Received May 29, 2003
Accepted January 9, 2004
A case of Lactobacillus aortic valve endocarditis in a 53-year-old immunocompetent patient with past history of rheumatic fever is reported. Clinical symptoms began after a dental extraction and the patient's diet included several yogurts per day. Blood, bone marrow cultures and the replaced aortic valve were positive for Lactobacillus. The clinical isolate was identified as Lactobacillus casei by 16S rDNA sequencing.
The GenBank accession number for the 16S rDNA sequence reported in this paper is AF526388.
 |
Introduction
|
|---|
Lactobacillus species include a diverse assemblage of Gram-positive, catalase-negative, non-sporulating, aerobic or facultative anaerobic, rod-shaped bacteria (Collins et al., 1991). They inhabit a wide variety of habitats, including the gastrointestinal tracts of animals and phytosphere, and are traditionally used in the manufacture of fermented foods and, in functional foods, as probiotics (Mattila-Sandholm et al., 1999). These micro-organisms are rarely infectious and their presence as commensals in the gastrointestinal tract is associated with protection against pathogens, stimulation of the immune system and positive effects on colonic health and host nutrition (Falk et al., 1998; Hooper et al., 2001; De Champs et al., 2003). Although lactobacilli are usually considered contaminants in blood cultures, they have been identified in some clinical reports as causal agents of dental caries, infectious endocarditis, urinary tract infections, corioamniotitis, endometritis, meningitis and intra-abdominal, liver and spleen abscesses (Husni et al., 1997). Commonly, these infections can be correlated with previous illnesses (recent surgery, transplants, valvulopathy, diabetes mellitus, AIDS and cancer) with either immunosupressive therapy or antibiotic treatment, which could promote the development or the selection of the micro-organism. Here, we describe a case of aortic valve endocarditis caused by Lactobacillus casei in a 53-year-old immunocompetent patient with a past history of rheumatic fever.
 |
Case Report
|
|---|
A 53-year-old male was admitted to hospital with a history of persistent fever. The patient had a past medical history of rheumatic fever and reported a dental extraction 3 months before admission. Further history was unremarkable, except for his diet, which included several yogurts per day. Two weeks after dental extraction, the patient noted fever associated with muscle and joint pain. He improved markedly on treatment with oral doxycycline (100 mg twice a day) for 2 weeks. However, symptoms reappeared shortly after treatment, and he was admitted to the Department of Infectious Diseases.
On examination, he had a high fever (38.3 °C), a heart murmur and splenomegaly, without any other abnormalities. Results from blood tests showed anaemia (Hb 11.2 g dl1) and a raised erythrocyte sedimentation rate (82 mm h1). Three aerobic blood and bone marrow cultures yielded a Gram-positive rod, which was sensitive to chloramphenicol and tetracycline, and resistant to penicillin and vancomycin. The patient was treated again with doxycycline for 2 weeks, without changes in the fever pattern. At this point, a change in the existing heart murmur was noted. Although the previous transthoracic cardiac ultrasound had shown no abnormalities, the continued presence of fever, anaemia and a changing heart murmur did not allow us to exclude the possibility of an endocarditis. A repeated transoesophagic cardiac ultrasound showed vegetation on the aortic valve. A diagnosis of endocarditis caused by a Gram-positive rod was made.
The patient was started on doxycycline and gentamicin, followed by piperacillin-tazobactam and finally imipenem. However, on this treatment, he showed no clinical improvement but, rather, continued with progressive weight loss, and finally became haemodynamically unstable. The patient underwent valve replacement surgery and was treated with doxycycline. The same Gram-positive rod isolated from the blood and bone marrow cultures was isolated from the culture of the removed valve. Eight months after surgery, the patient was fully recovered.
 |
Microbiological Investigation
|
|---|
Blood cultures were collected into BacT/ALERT FA bottles and the heart valve was cultured in brain heart infusion broth. A Gram-positive non-haemolytic bacillus was isolated from all samples. The isolated bacillus was subcultured onto Columbia blood agar (bioMérieux) at 37 °C in aerobiosis. Biochemical tests performed on the isolate showed that reactions for catalase and oxidase were negative. Susceptibility tests were performed by the BSAC comparative method (Andrews, 2001) on DST agar (Oxoid) supplemented with 5 % blood. The isolate was susceptible to chloramphenicol, tetracycline, piperacillin-tazobactam, imipenem, rifampicin, erythromycin, clindamycin and gentamicin, and resistant to penicillin, ampicillin, cephradine, cefuroxime, cefotaxime, ceftazidime, vancomycin, amikacin, colistin, ciprofloxacin and fusidic acid. Phenotypic tests performed with API Coryne and API 32A systems (bioMérieux) did not result in an acceptable identification, although API 32A suggested the possibility of Lactobacillus acidophilus.
The need for a reliable diagnosis confirmation prompted sequencing of the 16S rDNA of the organism. Cells used for DNA extraction were grown for approximately 16 h at 30 °C in 20 ml MRS broth (Merck). Genomic DNA was isolated by the guanidium thiocyanate method (Pitcher et al., 1989). 16S rDNA was amplified with universal primers pA and pH (Edwards et al., 1989). The PCR amplification protocol was 35 cycles of 1 min denaturation at 94 °C, 1 min annealing at 50 °C and 2 min extension at 72 °C, after an initial denaturation step of 94 °C for 4 min, with a final extension step (72 °C for 5 min). The amplified fragment was purified with Concert rapid PCR purification system (Gibco-BRL) and cloned into pGEM-T Easy cloning vector (Promega), according to the manufacturer's instructions. Recombinant plasmids were obtained by blue-white selection of Escherichia coli MRF' clones. Plasmid DNA was extracted with Concert high purity plasmid miniprep system (Gibco-BRL). Selected clones were sequenced in an automated DNA capillary sequencer CEQ 2000-XL (Beckman Coulter) by a dye-labelled dideoxy termination method (DTCS, dye terminator cycle sequencer start kit; Beckman Coulter). Five sequencing reactions were performed using vector primers T7 and SP6 and the internal primers 519R (5'-GWATTACC GCGGCKGCTG-3'), 907R (5'-CCGTCAATTCMTTTRA GTTT-3') and 926F (5'-AAACTYAAAKGAATTG ACGG-3'). The sequence was compared with GenBank entries using BLAST (Altschul et al., 1997), which indicated 99 % similarity to L. casei; the strain was therefore identified as L. casei HSM357872. The 1562 bp sequence of the 16S rDNA determined in this study was deposited in the GenBank database under accession number AF526388.
 |
Discussion
|
|---|
Although infections are dependent on the aetiological agent, the degree of illness may be related to the clinical history of the patient (Husni et al., 1997; Wallet et al., 2002), namely underlying diseases or immunocompromised states. So, infections caused by micro-organisms usually regarded as non-invasive tend to be underestimated and, in some conditions, become true severe illness. Reports of human infections caused by micro-organisms that are usually not pathogenic have become more frequent in recent years (Ha et al., 1999; Olano et al., 2001; Frebourg et al., 2002; Flaherty et al., 2003). Usually, immunocompromised children and elderly individuals are more susceptible to this kind of infection. Bacteraemia caused by probiotic organisms is rare but underestimated, since they are normally regarded as contaminants and their role as primary invaders is also not always easy to establish. Other drawbacks in the identification of unusual disease agents by conventional methods are (i) that they are fastidious, (ii) that many involve some degree of subjective evaluation and (iii) that the regular procedures used in hospitals are, obviously, not designed for them (Wallet et al., 2002). As the 16S rRNA nucleotide sequence is available in databases for most bacterial species, 16S rDNA sequencing becomes a valuable identification strategy for such micro-organisms.
Since no other micro-organism was isolated from all clinical samples (blood, bone marrow and aortic valve), patient bacteraemia was caused primarily by Lactobacillus with no association to polymicrobial infections, contrary to other reports (Antony et al., 1996; Husni et al., 1997). A correlation was also found between the consumption of several yogurts per day and the bacteraemia after dental extraction, caused by bacteria usually related to probiotics. Although no direct link for the development of endocarditis by L. casei and yogurt ingestion could be established, the past history of rheumatic fever could be responsible for a locus of minor resistance in the aortic valve, allowing the establishment of the bacteria and the development of the endocarditis. Although Lactobacillus sp. bacteraemia is rarely considered life-threatening, the further development of serious and fatal illness can be promoted by several underlying clinical conditions, in which immunosuppressive therapy and use of sub-optimal antimicrobials or antibiotics without activity against lactobacilli are usually associated (Bayer et al., 1978; Husni et al., 1997; Wallet et al., 2002). Since the patient was immunocompetent and the Lactobacillus isolate was susceptible in vitro to the antibiotics used in clinical treatment, the hypothesis of sub-optimal dosages cannot be ruled out.
Although the increased consumption of dairy products does not appear to promote an increase in Lactobacillus sp. bacteraemia (Salminen et al., 2002), it is noteworthy that a probiotic strain of Lactobacillus rhamnosus has been involved in several bacteraemia cases (Salminen et al., 2002) and Lactobacillus populations can survive in gastrointestinal tracts of humans after oral administration (De Champs et al., 2003). Regarding the association of Lactobacillus endocarditis with ingestion of dairy products and dental extraction procedures, conflicting results have been reported (Presterl et al., 2001; Wallet et al., 2002).
Even though the consumption of probiotics and dental manipulations cannot be considered risk factors in the development of diseases caused by bacteria usually considered non-pathogenic, specific individual clinical histories (namely, underlying diseases and the usage of specific treatments) should be taken into account.
This report of a L. casei aortic valve endocarditis in an immunocompetent individual should alert both clinicians and microbiologists to the possibility of unusual pathogens causing serious illnesses. 16S rDNA molecular identification represents a powerful tool in diagnosis confirmation of infrequent pathogens.
 |
References
|
|---|
Altschul, S. F., Madden, T. L., Schäffer, A. A., Zhang, J., Zhang, Z., Miller, W. & Lipman, D. J. (1997). Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 25, 33893402.[Abstract/Free Full Text]
Andrews, J. M. (2001). BSAC standardized disc susceptibility testing method.BSAC Working Party on Susceptibility Testing. J Antimicrob Chemother 48, 4357.[Abstract/Free Full Text]
Antony, S. J., Stratton, C. W. & Dummer, J. S. (1996). Lactobacillus bacteremia.Description of the clinical course in adult patients without endocarditis. Clin Infect Dis 23, 773778.[Medline]
Bayer, A. S., Chow, A. W., Betts, D. & Guze, L. B. (1978). Lactobacillemia report of nine cases.Important clinical and therapeutic considerations. Am J Med 64, 808813.[CrossRef][Medline]
Collins, M. D., Rodrigues, U., Ash, C., Aguirre, M., Farrow, J. A. E., Martinez-Murcia, A., Phillips, B. A., Williams, A. M. & Wallbanks, S. (1991). Phylogenetic analysis of the genus Lactobacillus and related lactic acid bacteria as determined by reverse transcriptase sequencing of 16S rRNA. FEMS Microbiol Lett 77, 512.[CrossRef]
De Champs, C., Maroncle, N., Balestrino, D., Rich, C. & Forestier, C. (2003). Persistence of colonization of intestinal mucosa by a probiotic strain, Lactobacillus casei subsp.rhamnosus Lcr35, after oral consumption. J Clin Microbiol 41, 12701273.[Abstract/Free Full Text]
Edwards, U., Rogall, T., Blocker, H., Emde, M. & Bottger, E. C. (1989). Isolation and direct complete nucleotide determination of entire genes.Characterization of a gene coding for 16S ribosomal RNA. Nucleic Acids Res 17, 78437853.[Abstract/Free Full Text]
Falk, P. G., Hooper, L. V., Midtvedt, T. & Gordon, J. I. (1998). Creating and maintaining the gastrointestinal ecosystem: what we know and need to know from gnotobiology. Microbiol Mol Biol Rev 62, 11571170.[Abstract/Free Full Text]
Flaherty, J. D., Levett, P. N., Dewhirst, F. E., Troe, T. E., Warren, J. R. & Johnson, S. (2003). Fatal case of endocarditis due to Weissella confusa. J Clin Microbiol 41, 22372239.[Abstract/Free Full Text]
Frebourg, N. B., Berthelot, G., Hocq, R., Chibani, A. & Lemeland, J.-F. (2002). Septicemia due to Pasteurella pneumotropica: 16S rRNA sequencing for diagnosis confirmation. J Clin Microbiol 40, 687689.[Abstract/Free Full Text]
Ha, G. Y., Yang, C. H., Kim, H. & Chong, Y. (1999). Case of sepsis caused by Bifidobacterium longum. J Clin Microbiol 37, 12271228.[Abstract/Free Full Text]
Hooper, L. V., Wong, M. H., Thelin, A., Hansson, L., Falk, P. G. & Gordon, J. I. (2001). Molecular analysis of commensal host-microbial relationships in the intestine. Science 291, 881884.[Abstract/Free Full Text]
Husni, R. N., Gordon, S. M., Washington, J. A. & Longworth, D. L. (1997). Lactobacillus bacteremia and endocarditis: review of 45 cases. Clin Infect Dis 25, 10481055.[Medline]
Mattila-Sandholm, T., Blum, S., Collins, J. K. & 18 other authors (1999). Probiotics: towards demonstrating efficacy. Trends Food Sci Technol 10, 393399.[CrossRef]
Olano, A., Chua, J., Schroeder, S., Minari, A., La Salvia, M. & Hall, G. (2001). Weissella confusa (Basonym: Lactobacillus confusus) bacteremia: a case report. J Clin Microbiol 39, 16041607.[Abstract/Free Full Text]
Pitcher, D. G., Saunders, N. A. & Owen, R. J. (1989). Rapid extraction of bacterial genomic DNA with guanidium thiocyanate. Lett Appl Microbiol 8, 151156.
Presterl, E., Kneifel, W., Mayer, H. K., Zehetgruber, M., Makristathis, A. & Graninger, W. (2001). Endocarditis by Lactobacillus rhamnosus due to yogurt ingestion. Scand J Infect Dis 33, 710714.[CrossRef][Medline]
Salminen, M. K., Tynkkynen, S., Rautelin, H., Saxelin, M., Vaara, M., Ruutu, P., Sarna, S., Valtonen, V. & Järvinen, A. (2002). Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland. Clin Infect Dis 35, 11551160.[CrossRef][Medline]
Wallet, F., Dessein, R., Armand, S. & Courcol, R. J. (2002). Molecular diagnosis of endocarditis due to Lactobacillus casei subsp.rhamnosus. Clin Infect Dis 35, 117119.
This article has been cited by other articles:

|
 |

|
 |
 
V. Vankerckhoven, P. Moreillon, S. Piu, M. Giddey, G. Huys, M. Vancanneyt, H. Goossens, and J. M. Entenza
Infectivity of Lactobacillus rhamnosus and Lactobacillus paracasei isolates in a rat model of experimental endocarditis
J. Med. Microbiol.,
August 1, 2007;
56(8):
1017 - 1024.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Isakow, L. E. Morrow, and M. H. Kollef
Probiotics for Preventing and Treating Nosocomial Infections: Review of Current Evidence and Recommendations
Chest,
July 1, 2007;
132(1):
286 - 294.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-L. Hahn, H. A. Schenkein, and J. G. Tew
Endocarditis-Associated Oral Streptococci Promote Rapid Differentiation of Monocytes into Mature Dendritic Cells
Infect. Immun.,
August 1, 2005;
73(8):
5015 - 5021.
[Abstract]
[Full Text]
[PDF]
|
 |
|